MedPath

INDOCO REMEDIES LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

17

Active:0
Completed:0

Trial Phases

3 Phases

Phase 1:2
Phase 4:6
Not Applicable:7

Drug Approvals

36

PHILIPPINES:26
FDA:10

Drug Approvals

Lacosamide

Approval Date
Mar 9, 2022
FDA

ACETYLCYSTEINE

Approval Date
Mar 1, 2022
FDA

NEOSTIGMINE METHYLSULFATE

Approval Date
Aug 25, 2021
FDA

apixaban

Approval Date
Jun 15, 2021
FDA

DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE

Approval Date
Feb 16, 2021
FDA

Dorzolamide Hydrochloride

Approval Date
Jan 8, 2021
FDA

Olanzapine

Approval Date
Aug 14, 2020
FDA

Succinylcholine Chloride

Approval Date
May 25, 2020
FDA

Febuxostat

Approval Date
Jan 13, 2020
FDA

Brimonidine Tartrate

Approval Date
Dec 27, 2018
FDA

Clinical Trials

Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials

Not Applicable
7 (46.7%)
Phase 4
6 (40.0%)
Phase 1
2 (13.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.